Mannatech (NASDAQ:MTEX) Coverage Initiated by Analysts at StockNews.com

Research analysts at StockNews.com assumed coverage on shares of Mannatech (NASDAQ:MTEX) in a research report issued to clients and investors on Sunday. The firm set a “buy” rating on the stock.

Mannatech Stock Performance

Shares of MTEX opened at $7.82 on Friday. The business has a 50-day simple moving average of $7.74 and a two-hundred day simple moving average of $7.54. The company has a quick ratio of 0.62, a current ratio of 1.17 and a debt-to-equity ratio of 0.54. Mannatech has a 52 week low of $6.75 and a 52 week high of $10.51. The stock has a market cap of $14.70 million, a price-to-earnings ratio of -12.41 and a beta of 1.17.

Mannatech (NASDAQ:MTEX) last released its earnings results on Tuesday, August 13th. The company reported ($0.33) earnings per share (EPS) for the quarter. Mannatech had a negative return on equity of 11.87% and a negative net margin of 0.97%. The firm had revenue of $27.74 million during the quarter.

Insider Transactions at Mannatech

In related news, Director Larry A. Jobe sold 16,288 shares of Mannatech stock in a transaction on Monday, September 9th. The shares were sold at an average price of $7.75, for a total transaction of $126,232.00. Following the transaction, the director now owns 54,721 shares in the company, valued at approximately $424,087.75. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 41.50% of the company’s stock.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.